Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Baylor Genetics | RCV003466136 | SCV004190946 | uncertain significance | DDX41-related hematologic malignancy predisposition syndrome | 2023-09-27 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV003779008 | SCV004633880 | likely benign | not provided | 2024-04-15 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV005323439 | SCV005989907 | likely benign | Inborn genetic diseases | 2025-02-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |